
Global Osteoarthritis Market (IA Injections, NSAIDs & Analgesics): Insights, Trends & Forecast (2022-2026)
Description
Global Osteoarthritis Market (IA Injections, NSAIDs & Analgesics): Insights, Trends & Forecast (2022-2026)
The global osteoarthritis market revenues are forecasted to touch US$12.14 billion in 2026, growing at a CAGR of 9.84% for the period spanning 2022 to 2026.
Factors such as increasing occurrence of osteoarthritis, growing geriatric population, rising healthcare expenditure per capita, growing obese population and improving consumer confidence index are expected to drive the market growth. However, growth of the industry would be challenged by associated business risk, patient health-associated risk and stringent regulations. A few notable trends include growth in pharmaceutical R&D expenditures, progressing product pipeline, advancement in osteoarthritis treatments and growth in online pharmaceutical sales.
The global osteoarthritis market by treatment type is segmented into categories i.e. IA Injections (corticosteroids and HA) and Drugs (NSAIDs & Analgesics). Among them, IA injections held the largest share of the industry revenues due to growth in prevalence of joint disorders across the world.
The fastest growing regional market is North America. The growth was supported by growth in geriatric population, surge in HA injections demand, rise in sports injuries and development in e-commerce industry. The U.S. is the largest market and is already well-penetrated at developed market levels.
Scope of the report:
The global osteoarthritis market revenues are forecasted to touch US$12.14 billion in 2026, growing at a CAGR of 9.84% for the period spanning 2022 to 2026.
Factors such as increasing occurrence of osteoarthritis, growing geriatric population, rising healthcare expenditure per capita, growing obese population and improving consumer confidence index are expected to drive the market growth. However, growth of the industry would be challenged by associated business risk, patient health-associated risk and stringent regulations. A few notable trends include growth in pharmaceutical R&D expenditures, progressing product pipeline, advancement in osteoarthritis treatments and growth in online pharmaceutical sales.
The global osteoarthritis market by treatment type is segmented into categories i.e. IA Injections (corticosteroids and HA) and Drugs (NSAIDs & Analgesics). Among them, IA injections held the largest share of the industry revenues due to growth in prevalence of joint disorders across the world.
The fastest growing regional market is North America. The growth was supported by growth in geriatric population, surge in HA injections demand, rise in sports injuries and development in e-commerce industry. The U.S. is the largest market and is already well-penetrated at developed market levels.
Scope of the report:
- The report provides a comprehensive analysis of the global osteoarthritis market, segmented into IA Injections and Drugs (Analgesics and NSAIDs).
- The major regional markets (North America, Europe and Asia-Pacific) have been analysed along with country coverage of US.
- The market dynamics such as growth drivers, market trends and challenges are analysed in-depth.
- The company profiles of leading players i.e. Johnson & Johnson, Novartis AG, Bayer AG, GlaxoSmithKline Plc, Pfizer Inc. and Sanofi S.A. are also presented in detail.
- Osteoarthritis Therapeutics Manufacturers
- Ingredient Suppliers
- End Users
- Consulting Firms
- Investment Banks
- Government Bodies & Regulating Authorities
Table of Contents
95 Pages
- 1. Market Overview
- 1.1 Introduction
- 1.2 Causes
- 1.3 Symptoms
- 1.4 Diagnosis
- 1.5 Treatment
- 2. Global Osteoarthritis Market Analysis
- 2.1 Global Osteoarthritis Market Value
- Table 1: Global Osteoarthritis Market Value (2017-2021)
- 2.2 Global Osteoarthritis Market Value Forecast
- Table 2: Global Osteoarthritis Market Value Forecast (2022-2026)
- 2.3 Global Osteoarthritis Market Value by Anatomy Type
- Table 3: Global Osteoarthritis Market Value by Anatomy Type (2021)
- 2.3.1 Global Knee Osteoarthritis Market Value
- Table 4: Global Knee Osteoarthritis Market Value (2017-2021)
- 2.3.2 Global Knee Osteoarthritis Market Value Forecast
- Table 5: Global Knee Osteoarthritis Market Value Forecast (2022-2026)
- 2.3.3 Global Knee Osteoarthritis Market Value by Region
- Table 6: Global Knee Osteoarthritis Market Value by Region (2021)
- 2.4 Global Osteoarthritis Market Value by Treatment Type
- Table 7: Global Osteoarthritis Market Value by Treatment Type (2021)
- 2.4.1 Global Osteoarthritis IA Injections Market Value
- Table 8: Global Osteoarthritis IA Injections Market Value (2017-2021)
- 2.4.2 Global Osteoarthritis IA Injections Market Value Forecast
- Table 9: Global Osteoarthritis IA Injections Market Value Forecast (2022-2026)
- 2.4.3 Global Osteoarthritis Drugs Market Value
- Table 10: Global Osteoarthritis Drugs Market Value (2017-2021)
- 2.4.4 Global Osteoarthritis Drugs Market Value Forecast
- Table 11: Global Osteoarthritis Drugs Market Value Forecast (2022-2026)
- 2.4.5 Global Osteoarthritis Drugs Market Value by Type
- Table 12: Global Osteoarthritis Drugs Market Value by Type (2021)
- 2.4.6 Global Osteoarthritis NSAIDs Market Value
- Table 13: Global Osteoarthritis NSAIDs Market Value (2017-2021)
- 2.4.7 Global Osteoarthritis NSAIDs Market Value Forecast
- Table 14: Global Osteoarthritis NSAIDs Market Value Forecast (2022-2026)
- 2.4.8 Global Osteoarthritis Analgesics Market Value
- Table 15: Global Osteoarthritis Analgesics Market Value (2017-2021)
- 2.4.9 Global Osteoarthritis Analgesics Market Value Forecast
- Table 16: Global Osteoarthritis Analgesics Market Value Forecast (2022-2026)
- 2.4.10 Global Osteoarthritis Drugs Market Value by Route of Administration
- Table 17: Global Osteoarthritis Drugs Market Value by Route of Administration (2021)
- 2.4.11 Global Osteoarthritis Parenteral Drugs Market Value
- Table 18: Global Osteoarthritis Parenteral Drugs Market Value (2017-2021)
- 2.4.12 Global Osteoarthritis Parenteral Drugs Market Value Forecast
- Table 19: Global Osteoarthritis Parenteral Drugs Market Value Forecast (2022-2026)
- 2.4.13 Global Osteoarthritis Oral Drugs Market Value
- Table 20: Global Osteoarthritis Oral Drugs Market Value (2017-2021)
- 2.4.14 Global Osteoarthritis Oral Drugs Market Value Forecast
- Table 21: Global Osteoarthritis Oral Drugs Market Value Forecast (2022-2026)
- 2.5 Global Osteoarthritis Market Value by Distribution Channels
- Table 22: Global Osteoarthritis Market Value by Distribution Channels (2021)
- 2.6 Global Osteoarthritis Market Value by Region
- Table 23: Global Osteoarthritis Market Value by Region (2021)
- 3. Regional Osteoarthritis Market Analysis
- 3.1 North America
- 3.1.1 North America Osteoarthritis Market Value
- Table 24: North America Osteoarthritis Market Value (2017-2021)
- 3.1.2 North America Osteoarthritis Market Value Forecast
- Table 25: North America Osteoarthritis Market Value Forecast (2022-2026)
- 3.1.3 North America Osteoarthritis Market Value by Anatomy Type
- Table 26: North America Osteoarthritis Market Value by Anatomy Type (2021)
- 3.1.4 North America Knee Osteoarthritis Market Value
- Table 27: North America Knee Osteoarthritis Market Value (2017-2021)
- 3.1.5 North America Knee Osteoarthritis Market Value Forecast
- Table 28: North America Osteoarthritis Market Value Forecast (2022-2026)
- 3.1.6 North America Osteoarthritis Market Value by Country
- Table 29: North America Osteoarthritis Market Value by Country (2021)
- 3.1.7 The U.S. Osteoarthritis Market Value
- Table 30: The U.S. Osteoarthritis Market Value (2017-2021)
- 3.1.8 The U.S. Osteoarthritis Market Value Forecast
- Table 31: The U.S. Osteoarthritis Market Value Forecast (2022-2026)
- 3.1.9 The U.S. Osteoarthritis Market Value by Treatment Type
- Table 32: The U.S. Osteoarthritis Market Value by Treatment Type (2021)
- 3.1.10 The U.S. Osteoarthritis IA Injections Market Value
- Table 33: The U.S. Osteoarthritis IA Injections Market Value (2017-2021)
- 3.1.11 The U.S. Osteoarthritis IA Injections Market Value Forecast
- Table 34: The U.S. Osteoarthritis IA Injections Market Value Forecast (2022-2026)
- 3.1.12 The U.S. Osteoarthritis Drugs Market Value
- Table 35: The U.S. Osteoarthritis Drugs Market Value (2017-2021)
- 3.1.13 The U.S. Osteoarthritis Drugs Market Value Forecast
- Table 36: The U.S. Osteoarthritis Drugs Market Value Forecast (2022-2026)
- 3.1.14 The U.S. Osteoarthritis Drugs Market Value by Type
- Table 37: The U.S. Osteoarthritis Drugs Market Value by Type (2021)
- 3.1.15 The U.S. Osteoarthritis NSAIDs Market Value
- Table 38: The U.S. Osteoarthritis NSAIDs Market Value (2017-2021)
- 3.1.16 The U.S. Osteoarthritis NSAIDs Market Value Forecast
- Table 39: The U.S. Osteoarthritis NSAIDs Market Value Forecast (2022-2026)
- 3.1.17 The U.S. Osteoarthritis Analgesics Market Value
- Table 40: The U.S. Osteoarthritis Analgesics Market Value (2017-2021)
- 3.1.18 The U.S. Osteoarthritis Analgesics Market Value Forecast
- Table 41: The U.S. Osteoarthritis Analgesics Market Value Forecast (2022-2026)
- 3.2 Europe
- 3.2.1 Europe Osteoarthritis Market Value
- Table 42: Europe Osteoarthritis Market Value (2017-2021)
- 3.2.2 Europe Osteoarthritis Market Value Forecast
- Table 43: Europe Osteoarthritis Market Value Forecast (2022-2026)
- 3.2.3 Europe Osteoarthritis Market Value by Anatomy Type
- Table 44: Europe Osteoarthritis Market Value by Anatomy Type (2021)
- 3.2.4 Europe Knee Osteoarthritis Market Value
- Table 45: Europe Knee Osteoarthritis Market Value (2017-2021)
- 3.2.5 Europe Knee Osteoarthritis Market Value Forecast
- Table 46: Europe Knee Osteoarthritis Market Value Forecast (2022-2026)
- 3.3 Asia-Pacific
- 3.3.1 Asia-Pacific Osteoarthritis Market Value
- Table 47: Asia-Pacific Osteoarthritis Market Value (2017-2021)
- 3.3.2 Asia-Pacific Osteoarthritis Market Value Forecast
- Table 48: Asia-Pacific Osteoarthritis Market Value Forecast (2022-2026)
- 3.3.3 Asia-Pacific Osteoarthritis Market Value by Anatomy Type
- Table 49: Asia-Pacific Osteoarthritis Market Value by Anatomy Type (2021)
- 3.3.4 Asia-Pacific Knee Osteoarthritis Market Value
- Table 50: Asia-Pacific Knee Osteoarthritis Market Value (2017-2021)
- 3.3.5 Asia-Pacific Knee Osteoarthritis Market Value Forecast
- Table 51: Asia-Pacific Knee Osteoarthritis Market Value Forecast (2022-2026)
- 4. Market Dynamics
- 4.1 Growth Drivers
- 4.1.1 Inclining Occurrence of Osteoarthritis
- Table 52: Global Osteoarthritis Population (2017-2021)
- 4.1.2 Growing Geriatric Population
- Table 53: Global Geriatric Population (2017-2021)
- 4.1.3 Rising Healthcare Expenditure per Capita
- Table 54: Global Healthcare Expenditure per Capita (2017-2021)
- 4.1.4 Growing Obese Population
- Table 55: The U.S. Obese Population (2017-2021)
- 4.1.5 Improving Consumer Confidence Index
- Table 56: Consumer Confidence Index in US and Europe (2017-2021)
- 4.2 Key Trends and Developments
- 4.2.1 Growth in Pharmaceutical R&D Expenditures
- Table 57: Global Pharmaceutical R&D Expenditures (2017-2021)
- 4.2.2 Progressing Product Pipeline
- 4.2.3 Advancement in Osteoarthritis Treatments
- 4.2.4 Growth in Online Pharmaceutical Sales
- Table 58: Global Online Pharmaceutical Sales (2022-2026)
- 4.3 Challenges-
- 4.3.1 Associated Business Risk
- 4.3.2 Patient Health-Associated Risk
- 4.3.3 Stringent Regulations
- 5. Company Profiles
- 5.1 Johnson & Johnson
- 5.1.1 Business Overview
- 5.2 Novartis AG
- 5.2.1 Business Overview
- 5.3 Bayer AG
- 5.3.1 Business Overview
- 5.4 GlaxoSmithKline Plc
- 5.4.1 Business Overview
- 5.5 Pfizer Inc.
- 5.5.1 Business Overview
- 5.6 Sanofi S.A.
- 5.6.1 Business Overview
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.